AKT1 and hepatocellular carcinoma: Specifically, AURKA can regulate miRNA expression and promote chemotherapy resistance in HCC by overexpressing the NF-κB/miR-21/PTEN/AKT signaling axis, emphasizing AURKA’s potential in modulating multiple signaling pathways [62].